Hyaluronidase: Allergy, Testing and Precautions
Hyaluronidase is the tool that makes it possible to break down hyaluronic acid in an excess, a nodule or a vascular occlusion. It is also a drug with its own reaction profile, and the most discussed one is allergy. The question that reaches the practice is a practical one: do I need to test first? And what about the patient who says they are allergic to bee stings?
This guide organizes what is known at a review level: why the enzyme can cause a reaction, what the Brazilian label says, what the literature discusses about insect venom, and how to weigh testing in elective use and in an emergency. It does not include testing technique, doses or dilutions. Storage and kit organization are in hyaluronidase in the practice; registration, compounding and purchasing are in hyaluronidase at ANVISA.
Why can hyaluronidase cause an allergy?
Hyaluronidase is an enzyme, that is, a protein. The most common medical presentations worldwide are extracted from animal tissue, typically bovine or ovine testes, and in other markets there are recombinant human versions. Proteins foreign to the body can be recognized by the immune system and trigger a hypersensitivity reaction.
Two points help in understanding the risk:
- Origin matters. Preparations of animal origin and with a lower degree of purification are the ones most associated with reactions in the literature. Recombinant human ones are described as less immunogenic, but not risk-free. Check the origin on the label and the leaflet of the product you have.
- Prior exposure matters. There are reports of sensitization after previous injections, which makes it relevant to ask whether the patient has already received the enzyme, in an aesthetic procedure or another medical setting, and how they reacted. A reaction on first exposure is also described, although rare.
What does the Brazilian label say?
There is a hyaluronidase registered as a drug in Brazil, extracted from bovine testes. The label of that presentation, consulted in October 2026, lists hypersensitivity to hyaluronidase as a contraindication, recommends sensitivity testing before starting treatment and describes local allergic reactions, such as erythema and, occasionally, nodules. The approved indications do not include breaking down fillers, so use in HOF is usually off-label, as detailed in hyaluronidase at ANVISA.
Compounded products do not have their own label: follow the container label, the pharmacy's technical data sheet and the prescription. If the technical data sheet of the product you use gives guidance on testing or additional contraindications, it goes into your protocol.
Does a bee or wasp allergy increase the risk?
This is the point that raises the most doubt. The venom of bees, wasps and other hymenopterans contains hyaluronidase among its allergens. Hence the hypothesis that someone allergic to the sting could also react to the enzyme used in medicine.
What the literature shows so far is a mixed picture:
| Point | What is discussed |
|---|---|
| Basis of the hypothesis | Venom hyaluronidase is a known allergen in people allergic to hymenopterans |
| Difference in origin | The medical enzyme comes from mammals; the venom one from insects, with a different structure |
| Studies in venom-allergic patients | Small and with differing results: some found no cross-reaction, others found sensitization in some of the allergic patients, especially to wasp |
| Previous venom immunotherapy | Appears as a factor that may change the response, with no firm conclusion |
| Practical conclusion | Cross-reaction is neither proven nor ruled out; the history weighs in the decision |
In practice, a history of reaction to an insect sting, especially a systemic reaction, is a warning sign. It does not automatically forbid use, but it enters the reasoning about prior testing, the care setting and preparation for a reaction. Patients with a known severe allergy may benefit from an allergist's evaluation before elective use.
Which questions should the medical history include?
The best time to find out about an allergy is not when the enzyme is already needed. The questions below should be in the medical history of every patient who will receive hyaluronic acid, not just on the day of the correction. The complete outline is in medical history in HOF.
| Question | Why it matters |
|---|---|
| Have you had a reaction to a bee, wasp or ant sting? Which one? | Basis of the cross-reaction hypothesis; a systemic reaction weighs more |
| Have you received hyaluronidase before? Did you have any reaction? | Prior exposure and sensitization |
| Do you have other severe allergies, asthma or an episode of anaphylaxis? | Higher-risk profile and worse outcome in a reaction |
| Are you on immunotherapy for venom allergy? | May alter the response, according to part of the literature |
| Do you take medications that interfere with treating a reaction? | Some, such as beta-blockers, can make anaphylaxis harder to manage; the professional assesses this |
| Is there active infection or inflammation in the area? | The label lists a restriction in infected areas |
Leave the insect sting question written out literally on the form. "Any allergies?" tends to get "no," because the patient thinks of medications and food, not the bee from years ago. Record the answer, even if negative, in the patient record.
To test or not to test: how does the professional decide?
There is no single consensus. Guidelines and reviews on filler complications diverge: some recommend testing before every elective use, others reserve it for patients with risk factors, and all agree that a vascular emergency does not wait for the test. How to perform the test and read the result follows the label, the technical data sheet and the professional's protocol, and is not described here.
What usually enters the decision:
- Nature of the use. Elective correction (excess, nodule, Tyndall effect) allows planning, testing and waiting for the reading. Vascular occlusion does not.
- Patient history. Venom allergy, previous reaction to the enzyme or significant atopy.
- Product. Origin, degree of purification and what the label or technical data sheet says.
- Limits of the test. A negative result does not guarantee the absence of a reaction, and the test itself is an exposure. A delayed reaction may appear after the reading window.
And in vascular occlusion?
When occlusion by hyaluronic acid is suspected, the risk of necrosis and visual damage is weighed against the risk of allergy, and treatment is an emergency. Complication management guidelines do not recommend delaying the enzyme to test. This is exactly why allergy history-taking must be done before the filler and why the practice must be ready to handle a severe reaction at the same moment.
How to tell an allergic reaction from an expected effect?
After hyaluronidase, some swelling, erythema and tenderness at the site are common and usually resolve within hours to a few days. The table helps separate what is expected from what calls for reassessment.
| Presentation | When it appears | Clues | Usual path |
|---|---|---|---|
| Expected local effect | Right after | Redness and swelling limited to the area, no intense itching | Advice and observation |
| Local hypersensitivity reaction | Minutes to hours | Redness and swelling beyond the area, itching, local hives | Assessment by the professional |
| Immediate systemic reaction | Minutes | Signs outside the face, respiratory or blood pressure | Emergency |
| Delayed reaction | Hours to days | Firm, red, tender swelling in the area | Reassessment and documentation |
| Persistence of product or prior swelling | Days | Residual volume, no inflammatory signs | Planned reassessment |
Swelling that appears months after a filler, unrelated to the enzyme, is a different condition, discussed in late swelling after hyaluronic acid.
How to document?
The filler's informed consent should mention that hyaluronidase may be needed and that it can also cause an allergic reaction. For elective use, use a specific form, such as the hyaluronidase consent template, which has a field for the testing decision.
In the patient record, document:
- the answers from the allergy history and prior use of the enzyme;
- the testing decision (done or not, and why) and the result, when done;
- product, origin, lot number and expiry;
- any reaction, with time, signs, management and progress.
Severe drug reactions can be reported to ANVISA (Brazil's health regulator) through the official adverse event reporting system.
How to explain it to the patient?
For the patient who asks whether the enzyme "takes everything out" or leaves the skin saggy, the text does hyaluronidase remove all the filler? has the conversation ready.
And in Harmy?
Hyaluronidase allergy checklist
- Question about bee, wasp or ant stings written into the medical history of every hyaluronic acid patient.
- Prior use of the enzyme and previous reactions asked about and recorded.
- Label or technical data sheet of the product in use read, including testing and contraindications.
- Product origin, lot number and expiry recorded.
- Decision on testing in elective use made and documented.
- Severe allergic reaction protocol and emergency kit ready and checked.
- Patient advised on signs of reaction and how to make contact.
- In a vascular emergency, treatment without delay and documentation right afterward.
Frequently asked questions
Can hyaluronidase cause an allergy?
It can. Hyaluronidase is a protein of animal origin in most presentations, and hypersensitivity reactions have been described, usually local (redness, itching, swelling) and, more rarely, generalized. That is why allergy history-taking and being prepared to handle a severe reaction are part of the routine for anyone who uses the enzyme.
Can someone allergic to bee stings use hyaluronidase?
Bee and wasp venom contains hyaluronidase, and the possibility of cross-reaction with the enzyme used in medicine is discussed in the literature, with results that do not settle the question. A history of reaction to an insect sting is information the professional weighs when deciding on prior testing, the care setting and preparation, and it must be documented.
Is it mandatory to test before injecting hyaluronidase?
The label of the presentation registered in Brazil recommends sensitivity testing before treatment, and many complication guidelines discuss testing in elective use. When vascular occlusion is suspected, treatment is not delayed to test. The decision belongs to the qualified professional, following the product label and their council's rules, and must be documented.
Does a negative allergy test guarantee there will be no reaction?
No. The test reduces uncertainty but does not eliminate the risk: false negatives occur and a reaction can appear with a later injection. Even with a negative test, the practice must be prepared to recognize and treat a reaction.
Harmy images are illustrative simulations generated by AI from the patient's photo to support the conversation between practitioner and patient. They are not a promise of results. Indication, technique, product and volume are solely the decision of the licensed practitioner. This content is for information only and does not replace a clinical assessment.